BlackRock, Inc.
- SEC CIK
- 0002012383
- Latest filing
- Aug 7, 2026
ACXP holding history
Acurx Pharmaceuticals, Inc. in every 13F filed by BlackRock, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACXP overviewAll 13F holders of ACXPFull Q2 2026 holdings
- Shares (Q2 2026)
- 60
- Value
- $93
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 60 | $93 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 60 | $223 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 60 | $149 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 60 | $257 | <0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | Holders |
| Q2 2025 | 1,204 | $615 | <0.1% | −33,041−96.5% | Reduced | Holders |
| Q1 2025 | 34,245 | $13.4K | <0.1% | +8,334+32.2% | Added | Holders |
| Q4 2024 | 25,911 | $21.1K | <0.1% | −2,624−9.2% | Reduced | Holders |
| Q3 2024 | 28,535 | $54.2K | <0.1% | – | No prior filing | Holders |